PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 7654809

Celiac sprue.

D Murphy
View original source ↗Export metadata ↓

Abstract

Celiac Sprue is a malabsorption disease (not to be confused with a food allergy or hypersensitivity to food products) that can occur at any age. This disease is characterized by changes in the mucosal lining of the small intestine. The mucosal lining is damaged by protein fragments of gliadin, which is found in gluten (wheat, rye, barley, oats), and the small intestine is unable to carry out its main functions of digestion and absorption. The treatment for this disease is to discontinue gluten from the diet permanently. Once gluten is removed from the diet, the small intestine begins to heal itself. As the healing process continues, digestion and absorption resume. Celiac Sprue does not go away. A gluten-free diet must be maintained for the rest of one's life.

Explore related subjects

Celiac DiseaseGlutensHumansIntestinal AbsorptionMenu PlanningSelf-Help GroupsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D Murphy. Celiac sprue.. https://pubmed.ncbi.nlm.nih.gov/7654809/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Involvement of macrophage migration inhibitory factor gene in celiac disease susceptibility.

The MIF gene has been associated with several diseases with inflammatory and autoimmune background, such as ulcerative colitis, rheumatoid arthritis and systemic lupus erythematosus. We aimed at testing the influence of two functional MIF promoter variants in celiac disease (CD) susceptibility. A (CAAT)(5-8) tetranucleotide repeat at position -794 and a single-nucleotide polymorphism at -173G/C were analyzed in the Spanish population (531 patients and 887 healthy controls). chi(2) statistics or Fisher exact test were used for comparisons. The -173C allele significantly increased risk ((CC+GC) vs GG: odds ratio (OR) (95% confidence interval (CI))=1.41 (1.10-1.81); P=0.005), as did carriage of the (CAAT)(7) allele (OR (95% CI)=1.36 (1.02-1.82); P=0.03) and of the haplotype (CAAT)(7)//-173C (OR (95% CI)=1.33 (1.00-1.76); P=0.04). Our data evidence for first time the role of the MIF gene increasing predisposition to CD. A common effect of MIF variants seems to underlie the etiology of these complex conditions.

Celiac Disease↗
PubMed2007

Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4.

Genome-wide scans have detected linkage to celiac disease (CD) in several genomic locations, including 19q13.4. Killer immunoglobulin-like receptor (KIR) genes map to the region and encode receptors of natural killer (NK) cells and certain T cells that modulate cytolitic activity through interactions with HLA class I ligands, participating in the innate immune response. We performed KIR genotyping in a group of 70 CD patients of Basque origin and compared gene content, genotype and haplotype frequencies to ethnically matched blood-donors. The frequency of gene combination KIR2DL5B(+)/KIR2DL5A(-) was significantly higher in the disease group, and this result was confirmed in a second group of 343 CD patients and 160 controls of Spanish origin, suggesting an implication of this 'unexpressed' gene with increased susceptibility to CD (combined OR of 3.63 (95% CI: 1.76-7.51; P=0.0004)), possibly due to the lack of an efficient inhibitory signal. Our results support the role of the KIR gene cluster in celiac disease and replicate the CD-susceptibility locus at 19q13.4.

Celiac Disease↗